| ID | Name | CAS | Properties |
Inp |
| 38-835-3 |
5-Hydroxyindole-3-acetic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 2682.60 |
| 39-235-8 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)hexyloxy-
|
|
4 | 1844.00 |
| 39-541-8 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 3165.00 |
| 39-674-1 |
3-.beta.,19-Dihydroxy-5-androsten-17-one, MO TMS
|
|
4 | 2705.00 |
| 39-938-8 |
3«alpha»,12«beta»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
4 | [3154.00; 3221.00] |
| 40-031-2 |
3-«beta»,12-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 3145.00 |
| 40-908-9 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one, O-trimethylsilyl
|
18880-80-3 |
4 | 2622.00 |
| 40-944-9 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, O-methyloxime, (17«beta»)-
|
56210-83-4 |
4 | [2634.00; 2712.00] |
| 41-139-2 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»,5«beta»)-
|
10426-96-7 |
4 | [2495.00; 2574.50] |
| 41-590-1 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTMS
|
|
4 | 2550.00 |
| 41-928-6 |
1,5-Pentanediamine, N-(6-methoxy-8-quinolinyl)-N'-(1-methylethyl)-
|
86-78-2 |
4 | [2540.00; 2555.00] |
| 42-130-0 |
Androst-4-en-17«alpha»-methyl-17«beta»-ol-3-one, TMS
|
|
4 | [2791.00; 2826.00] |
| 42-377-7 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS(d9)
|
|
4 | 3155.00 |
| 42-392-0 |
4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-
|
19103-54-9 |
4 | 3232.60 |
| 42-488-4 |
5-«alpha»-Pregnane-17-«alpha»,20-«alpha»-diol, bis-TMS
|
|
4 | 2675.00 |
| 42-492-9 |
5«beta»-Androstane-3,17-dione, mono-TMS, (2-en)
|
|
4 | [2497.00; 2510.00] |
| 42-738-6 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 17,20-methylboronate
|
|
4 | 2585.00 |
| 42-986-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 3449.00 |
| 43-060-7 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, butyl ester
|
|
4 | 2267.00 |
| 43-393-8 |
(17«beta»)-2,3-Dimethoxy-17-[(trimethylsilyl)oxy]estra-1(10),2,4-triene
|
|
4 | 2817.60 |
| 43-867-2 |
5-(2-ethyl,5-methylheptanyl)-3-methyl-2H-pyran-2-one
|
|
4 | 1809.00 |
| 43-935-6 |
N-tert-Butyl-N'-acetyl-6-chloro-1,3,5-triazine-2,4-diamine
|
|
4 | 1898.00 |
| 44-110-0 |
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-N-[2-[(trimethylsilyl)oxy]ethyl]-
|
5630-81-9 |
4 | [1258.00; 1281.00] |
| 44-815-8 |
6-Chloro-N,N'-(cyclopropyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | [2048.58; 2086.66] |
| 45-216-2 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, TMS
|
|
4 | [2668.00; 2699.00] |
| 45-373-8 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2-pentyl ester
|
|
4 | 2175.00 |
| 45-619-5 |
3-«alpha»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 3167.00 |
| 45-802-1 |
3«alpha»,12«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 3410.00 |
| 46-137-9 |
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-methylpropyl)-
|
|
4 | 1908.00 |
| 46-390-8 |
3«beta»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 3409.00 |
| 46-416-9 |
5«beta»-Androstan-3«alpha»-ol-11,17-dione, MO
|
|
4 | 2543.00 |
| 46-908-3 |
3«alpha»,7«beta»-Dihydroxy-5«beta»-homocholanoic acid, MeTMS
|
|
4 | [3376.00; 3405.00] |
| 47-380-8 |
3-Buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 1
|
|
4 | 1986.00 |
| 49-242-9 |
5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile
|
|
4 | [2049.00; 2069.00] |
| 49-566-0 |
Androst-2,4-dien-3,17«beta»-diol, (3,17-O)-diTBDMSi
|
|
4 | [3197.00; 3252.00] |
| 49-725-3 |
N-isobutyl-2-(trimethylsilyloxy]-4,5-dihydro-1H-imidazole-1-carboxamide
|
|
4 | 1862.00 |
| 50-501-9 |
5«beta»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-89-9 |
4 | [2683.00; 2696.00] |
| 50-917-8 |
Silane, [[(17«beta»)-2-methoxyestra-1,3,5(10)-triene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
29825-47-6 |
4 | [2769.00; 2782.00] |
| 51-409-1 |
17-Epimetandienone (Androst-1,4-dien-17B-methyl-17A-ol-3-one), TMS
|
|
4 | 2668.00 |
| 51-594-6 |
2-(2-(2-(2-(2-(2-(2-Pentoxy-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethyl TMS ether
|
|
4 | 3077.40 |
| 51-755-7 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, methylboronate
|
|
4 | 2970.00 |
| 52-095-9 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 3,6-dimethyl-
|
|
4 | 1694.00 |
| 52-758-3 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)nonyloxy-
|
|
4 | 2116.00 |
| 52-766-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,24-triol, TMS
|
|
4 | 3298.00 |
| 53-570-0 |
17.alpha.,21-Dihydroxypregn-4-en-3,20-dione, 17,21-dimethylsilylene
|
|
4 | 2890.00 |
| 53-652-9 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 2515.00 |
| 54-970-5 |
Silane, dimethyl(dimethyl(2,5-dichlorophenyloxy)silyloxy)(2,5-dichlorophenoxy)-
|
|
4 | 2384.00 |
| 55-172-0 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)heptyloxy-
|
|
4 | 1937.00 |
| 55-533-9 |
1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
|
642-72-8 |
4 | [2350.00; 2414.00] |
| 56-004-5 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, bis-TMS
|
|
4 | 3220.00 |
| 56-144-0 |
3«alpha»-hydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 3321.00 |
| 56-164-8 |
5«beta»-Androst-1-ene-3,17-dione, mono-TMS
|
|
4 | [2452.00; 2468.00] |
| 56-753-4 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, dodecahydro-, [7S-(7«alpha»,7a«alpha»,14«alpha»,14a«alpha»)]-
|
486-87-3 |
4 | [2091.00; 2131.00] |
| 57-666-0 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, (17«alpha»)-
|
16134-45-5 |
4 | [2645.00; 2675.80] |
| 58-182-6 |
2-Thiopheneacetic acid, 2-methyloct-5-yn-4-yl ester
|
|
4 | 1761.00 |
| 59-004-2 |
2-Butanone, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 1
|
|
4 | 1961.00 |
| 59-692-9 |
2H-Imidazo[4,5-b]pyridin-2-one, 1,3-dihydro-
|
|
4 | 1740.00 |
| 59-731-5 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, ethyl ester
|
|
4 | 2326.00 |
| 59-880-0 |
Methyltestosterone (Androst-4-en-17A-methyl-17B-ol-3-one), TMS
|
|
4 | 2791.00 |
| 60-247-1 |
2,6-Pyridinedicarboxylic acid, 4-bromo-2-methoxybenzyl ethyl ester
|
|
4 | 2833.00 |
| 60-509-0 |
2-Thiopheneacetic acid, 2,6-dimethylnon-1-en-3-yn-5-yl ester
|
|
4 | 1895.00 |
| 61-252-4 |
2-Butanone, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 2
|
|
4 | 1976.00 |
| 61-991-4 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-bis-(ethenyl), 1,3-bis-(chloromethyl)
|
|
4 | 1550.00 |
| 62-409-9 |
N-tert-Butyl-N'-trimethylsilyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
|
4 | 1812.00 |
| 62-475-6 |
3-«beta»,17-«beta»-Dihydroxy-5-androsten-16-one, TMS
|
|
4 | 2795.00 |
| 62-513-3 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-methyl-), TMS
|
|
4 | 1960.00 |
| 62-566-5 |
2,6-Pyridinedicarboxylic acid, ethyl 5-methoxy-3-methylpent-2-yl ester
|
|
4 | 2152.00 |
| 62-839-2 |
(4,6-Dichloro-[1,3,5]triazin-2-yl)-(1,1,3,3-tetramethyl-butyl)-amine
|
|
4 | [1906.55; 1945.26] |
| 63-017-3 |
1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane
|
|
4 | 1512.00 |
| 63-024-5 |
Phosphorothioic acid, O-(6-ethoxy-2-ethyl-4-pyrimidinyl) O,O-dimethyl ester
|
38260-54-7 |
4 | [1780.00; 1824.00] |
| 63-147-9 |
1,5-Dimethyl-5-(6-oxocyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
4 | 2027.00 |
| 63-477-3 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, tris-TMS
|
|
4 | 2870.00 |
| 63-483-6 |
1,1,1-tris(Hydroxymethyl)propane, bis(tert-butyldimethylsilyl) ether
|
|
4 | 1819.40 |
| 64-045-1 |
1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol, trimethylsilyl- ether
|
|
4 | 2487.00 |
| 64-108-1 |
5-Chloro-N-(2-chloro-4-nitro-phenyl)-N-trimethylsilyl-2-trimethylsilyloxybenzamide
|
|
4 | 2652.00 |
| 64-755-3 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N4,N6-diacetyl
|
|
4 | 2337.00 |
| 64-814-7 |
3-Buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl), PFBO # 2
|
|
4 | 2029.00 |
| 64-891-2 |
2,6-Pyridinedicarboxylic acid, ethyl 2,4,4-trimethylpentyl ester
|
|
4 | 2090.00 |
| 64-949-8 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, methylboronate
|
|
4 | 2685.00 |
| 65-196-3 |
Cinnamic acid, 4-methoxy-3-(tert-butyldimethylsilyl)oxy-, tert-butyldimethylsilyl ester
|
|
4 | 2557.80 |
| 65-250-2 |
3«alpha»,16«beta»-Dihydroxy-5-androsten-17-one, di-TMS
|
|
4 | 2635.00 |
| 65-325-9 |
Estra-1,3,5(10)-trien-17-one, 2-methoxy-3-[(trimethylsilyl)oxy]-
|
29825-40-9 |
4 | 2815.40 |
| 65-893-9 |
Androstane-11,17-dione, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
5042-90-0 |
4 | [2611.00; 2622.00] |
| 66-380-7 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»,21-triol, methylboronate
|
|
4 | 2690.00 |
| 67-060-1 |
4-Androsten-17«beta»-ol-3-one (testosterone), MO-TMS
|
|
4 | 2645.00 |
| 67-507-5 |
3«alpha»,7«beta»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 3498.00 |
| 67-626-3 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«alpha»,5«alpha»)-
|
57711-45-2 |
4 | [2702.00; 2788.80] |
| 67-851-3 |
5-(2,5-dimethylheptanyl)-3-methyl-2H-pyran-2-one, diastereomer 2
|
|
4 | 1845.00 |
| 67-973-8 |
2,3,16,17-Tetrakis[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (16«alpha»,17«beta»)-
|
51497-46-2 |
4 | 3039.00 |
| 69-135-6 |
bis[(3,7-Dimethyloct-6-en-1-yl)oxy](dimethyl)silane
|
|
4 | 2085.80 |
| 69-379-6 |
3-Amino-3-(4-fluorophenyl)propionic acid, N-dimethylaminomethylene-, ethyl ester
|
|
4 | 1805.00 |
| 69-642-3 |
3«alpha»,6«alpha»-Dihydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | 3238.00 |
| 70-211-9 |
3«alpha»-Hydroxy-5«beta»-pregnan-20-one, O-trimethylsilyl
|
18880-83-6 |
4 | 2637.00 |
| 70-529-7 |
Cholanic acid, 3«alpha»,6«alpha»,7«alpha»-trihydroxy, Me-TMS
|
|
4 | [3302.00; 3320.00] |
| 70-820-3 |
5-(2,5-dimethylheptanyl)-3-methyl-2H-pyran-2-one, diastereomer 1
|
|
4 | 1836.00 |
| 71-157-9 |
Silane, [[(3«beta»,17«beta»)-17-methylandrost-5-ene-3,17-diyl]bis(oxy)]bis[trimethyl-
|
39780-59-1 |
4 | 2732.00 |
| 71-481-9 |
17«beta»-Hydroxy-5«alpha»-androstan-3-one, trimethylsilyl ether
|
18899-43-9 |
4 | 2614.80 |
| 71-643-9 |
Pregn-5-en-20-one, 3«beta»-(trimethylsiloxy)-, O-methyloxime
|
25830-38-0 |
4 | 2834.00 |
| 71-785-2 |
4-(2,3-Dihydroxy-3-methylbutoxy)furo(3,2-g)chromen-7-one
|
24724-52-5 |
4 | 2765.10 |
| 72-834-6 |
1,3,5(10)-Oestratriene-3,17.beta.-diol, 3-TBDMS-17-HFB
|
|
4 | 2849.00 |
|
« Previous Results
Next Results »
|